Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery

Eur J Surg Oncol. 2017 Apr;43(4):801-807. doi: 10.1016/j.ejso.2017.01.008. Epub 2017 Jan 29.

Abstract

Background: Laparoscopic gastrectomy (LG) is reported to be associated with faster recovery than open gastrectomy (OG); however, the influence of the surgical approach on initiation timing of adjuvant chemotherapy (AC) remains unclear.

Methods: This was a single-institutional retrospective observational study. Patients with pathological stage II/III gastric cancer undergoing LG with D2 lymphadenectomy (LG group: n = 74) were matched 1:1 with patients selected from 214 similar patients undergoing OG (OG group: n = 74), identically matching gender, age, pathological stage, and type of gastrectomy, and comparing AC initiation timing between the two groups. Factors associated with delayed initiation of AC were investigated in a multivariable analysis.

Results: AC was performed in 86.5% (LG) and 83.8% (OG) of patients (p = 0.64). The median time interval before AC was significantly shorter in the LG vs. OG group (5.7 vs. 6.6 weeks, respectively, p < 0.001), and significantly more patients received AC within 6 weeks (60.8% vs. 27.0%, p < 0.001). Independent factors associated with delayed initiation of AC (>6 weeks) were: morbidity (≥grade 3a; odds ratio (OR): 16.1, 95% confidence interval (CI): 1.86-143), open surgery (OR: 5.17, 95% CI: 2.50-13.1), and postoperative weight loss ≥ 8% (OR: 2.47, 95% CI: 1.07-5.71).

Conclusions: LG may be associated with shorter intervals before AC. Postoperative morbidity should be reduced as much as possible.

Keywords: Adjuvant chemotherapy; Case-control studies; Gastrectomy; Laparoscopy; Laparotomy; Stomach neoplasms.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Abdominal Abscess / epidemiology
  • Adult
  • Aged
  • Aged, 80 and over
  • Anastomotic Leak / epidemiology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Capecitabine
  • Case-Control Studies
  • Chemotherapy, Adjuvant / methods*
  • Cisplatin / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Drug Combinations
  • Female
  • Fluorouracil / analogs & derivatives
  • Fluorouracil / therapeutic use
  • Gastrectomy / methods*
  • Humans
  • Laparoscopy / methods*
  • Laparotomy
  • Lymph Node Excision
  • Male
  • Middle Aged
  • Organoplatinum Compounds / administration & dosage
  • Oxaliplatin
  • Oxaloacetates
  • Oxonic Acid / administration & dosage
  • Pancreatic Fistula / epidemiology
  • Postoperative Complications / epidemiology*
  • Retrospective Studies
  • Stomach Neoplasms / drug therapy*
  • Tegafur / administration & dosage
  • Time Factors
  • Time-to-Treatment

Substances

  • Drug Combinations
  • Organoplatinum Compounds
  • Oxaloacetates
  • Oxaliplatin
  • Deoxycytidine
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Capecitabine
  • Cisplatin
  • Fluorouracil

Supplementary concepts

  • XELOX